Hinoman

Company Overview

Snapshot

Founded in August 2012, Hinoman operates with 1–10 employees. The company has raised $15.8 million across two funding rounds. In March 2017, Ajinomoto invested in the company, signaling strong corporate interest in its plant-based protein solutions.

Business overview

Hinoman is an Israeli agriculture food tech company that cultivates Mankai, a proprietary Wolffia globosa strain, using an aquaponic greenhouse system. This tiny leaf vegetable offers a solution to nutritional challenges, providing complete protein, iron, B12, essential nutrients, polyphenols, vitamins, and minerals. Hinoman's product, Mankai, is designed to integrate into various foods and beverages, serving markets in Asia, the United States, Japan, and Israel within the Agriculture & Food Technologies sector.

Strategic signal

In October 2025, news emerged suggesting that Hinoman's Mankai superfood, grown in Be'eri, has the potential to achieve a significant valuation on Nasdaq. This indicates growing market recognition and investor confidence in the commercial viability and scalability of Hinoman's sustainable plant-based protein, positioning it as a key player in the evolving food tech landscape.

Company Intelligence Q&A

What is Hinoman's primary product?

Hinoman's primary product is Mankai, a proprietary Wolffia globosa strain of tiny leaf vegetable, cultivated using an aquaponic greenhouse system.

What are the nutritional benefits of Mankai?

Mankai contains a vast amount of complete protein, iron, B12, essential nutrients, polyphenols, vitamins, and minerals, which contribute to various health benefits.

Which company invested in Hinoman in March 2017?

In March 2017, Ajinomoto invested in Hinoman, supporting its plant-based protein production efforts.

What are the environmental advantages of Mankai cultivation?

Mankai cultivation offers several environmental advantages, including rapid reproduction for high yields, growth on non-arable land, no topsoil depletion, lower greenhouse gas emissions, no groundwater contamination, reliance on daylight, and recycled water usage.

What was the strategic outlook for Hinoman in October 2025?

In October 2025, it was reported that Hinoman's Mankai superfood had the potential to achieve a significant valuation on Nasdaq, highlighting its commercial promise.